Active Ingredient(s): Artemether + Lumefantrine
FDA Approved: * April 7, 2009
Pharm Company: * NOVARTIS PHARMS
Category: Malaria

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Coartem Overview

Artemether/lumefantrine, sold under the trade name Coartem among others, is a combination of the two medications artemether and lumefantrine.[1] It is used to treat malaria caused by Plasmodium falciparum that is not treatable with chloroquine.[1] It is not typically used to prevent malaria.[1] It is taken by mouth.[1] Common side effects include muscle and joint pains, fever, loss of appetite, and headache.[1] Se...

Read more Coartem Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Coartem Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Artemether + Lumefantrine
  • Tablet: 20mg + 120mg, 20mg/120mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Coartem: (3 results)

Sorted by National Drug Code
  • 0078-0568 Coartem (Artemether 20 mg / Lumefantrine 120 mg) Oral Tablet by Novartis Pharmaceuticals Corporation
  • 55695-020 Coartem Oral Tablet by Department of State Health Services, Pharmacy Branch
  • 76413-154 Coartem Oral Tablet by Central Texas Community Health Centers

Drugs with one or more similar ingredients: (3 results)